Cutting-Edge Mini-CLIA Tumor Marker Assay Solutions for Precision Diagnosis


Explore our advanced mini-CLIA tumor marker assay reagent, designed for accurate and reliable detection of cancer biomarkers. Elevate your diagnostic capabilities with our state-of-the-art chemiluminescence immunoassay system, available exclusively at our product center.

Mini-CLIA Tumor Marker Assay Solutions

Name

Specimen

LOD

Linearity(r>0.990)

AFP

Serum/Plasma

0.1ng/mL

0.5-1000ng/mL

CA15-3

Serum/Plasma

1U/mL

1.0-300U/mL

CA19-9

Serum/Plasma

1U/mL

1.0-2000U/mL

CA125

Serum/Plasma

1U/mL

1.0-5000U/mL

CEA

Serum/Plasma

0.2ng/mL

0.2-600ng/mL

t-PSA

Serum/Plasma

0.05ng/mL

0.1-100ng/mL

f-PSA

Serum/Plasma

0.01ng/mL

0.05-60ng/mL

Mini-CLIATumor Marker Reagents

Tumor Marker2

Reagent features:

● State-of-the-art Chemiluminescence test method

● Single test concept, one sample ,one cartridge, one result

● Precision: CV<10 %

● Original Reagents, Calibrators & Quality controls with traceability system

● 18 months actual period of validity, 90days calibration validity period

WechatIMG16


  • Previous:
  • Next:

  • Our Mini-CLIA Tumor Marker Assay Solutions offer a comprehensive range of assays for various tumor markers, ensuring precise and efficient diagnosis of cancer. Utilizing the latest chemiluminescence immunoassay technology, our reagents deliver unparalleled sensitivity and specificity in detecting biomarkers, surpassing traditional methods. Enhance your laboratory's capabilities with our innovative assay solutions, revolutionizing cancer diagnosis and patient care.

  • Previous:
  • Next: